November 19th is National Enteropathic Arthritis Day in Canada. This is the third year we acknowledge this special day. We have applied to illuminate several landmarks across Canada in EnA colors (purple). Keep an eye out on this page for updated landmarks!
Enteropathic arthritis is a spondyloarthritic condition and an invisible illness for many Canadians.
- Enteropathic arthritis is a form of inflammatory arthritis that can affect the spine and peripheral joints. The arthritis is associated with inflammation in the gut.
- Occurs in 0.06 to 0.5% of the population (source)
- About 10-20% of people with inflammatory bowel disease (IBD) will develop enteropathic arthritis. (source)
- The two most commonly known inflammatory bowel disease types are ulcerative colitis and Crohn’s disease.
To help support people living with Enteropathic Arthritis, we have provided and continue to provide many resources.
- Our Nov 22nd 2022webinar on Peripheral Spondyloarthritis & Enteropathic Arthritis : Featuring Dr. Walter Maksymowych (University of Alberta) Watch the recorded session.
- Our 2021 Chronic Disease Distress (Mental Health) webinar : 150 people attended this event virtually – with hundreds watching at a later time. Watch the recorded session.
- Our 2021 Quality of Life report : We asked over 850 people living with SpA how it affects various aspects of their lives. Read the report here.
- Niagara Falls: The Horseshoe falls will be illuminated in purple at 10:15 for a period of 15 minutes, to bring awareness to Enteropathic Arthritis (watch live here). The Peache Bridge will also be illuminated.
Read Kayla Jenkin’s story on her journey with EnA found here in The Calgary Herald
Kayla Jenkins knew something was wrong for years — as someone with a family history of inflammatory bowel disease (IBD), she knew her symptoms weren’t normal.
Read this study on the prevalence of SpA among patients with IBD
Background: Joint complaints such as spondyloarthritis and peripheral arthritis are the most common extraintestinal manifestations in patients with inflammatory bowel disease (IBD); however, the evaluation of these symptoms are poorly described.
Visit our page on Enteropathic Arthritis, HERE
Visit our page on Peripheral Spondyloarthritis, HERE